Effects of Acute Drug Administration on Emotion: a Review of Pharmacological MRI Studies
This review (2021) examined the effects of different drugs on neural responses to emotional stimuli and found that alcohol, analgesics, and psychedelics reduce neural reactivity to negative emotional stimuli in the amygdala and other brain regions and MDMA decreases activation during the presentation of negative images. In contrast, stimulants such as caffeine and modafinil increase brain activation while viewing emotional stimuli, and the effects of cannabinoids (cannabidiol and THC) are mixed.
Authors
- Harriet de Wit
- Anya Bershad
Published
Abstract
Purpose of Review: Many drug users claim to use drugs to cope with negative emotions, which may, in turn, result in persistent emotional blunting or anhedonia even when they are not using drugs. The purpose of this review is to describe the ways acute administration of psychoactive drugs impacts brain regions during emotion-related tasks, as a first step in understanding how drugs influence emotion processing in the brain.Recent Findings: Drugs have varying effects on neural responses to emotional stimuli. In general, alcohol, analgesics, and psychedelics reduce neural reactivity to negative emotional stimuli in the amygdala and other brain regions. Other drugs produce mixed effects: Stimulants such as caffeine and modafinil increase brain activation while viewing emotional stimuli, whereas MDMA decreases activation during presentation of negative images. The effects of cannabinoids (cannabidiol and THC) are mixed. There are also inconsistent findings on the associations between neural responses to emotional stimuli and subjective drug effects.Summary: Consistent with the notion that individuals might use drugs non-medically to diminish the experience of negative emotions, several drugs of abuse decrease neural responses to negative stimuli in limbic brain regions. These neural actions may underlie the reported “emotional blunting” of drugs, which may contribute to drug-seeking behavior. Future work is needed to examine these limbic responses in relation to self-reports of changes in affect, both during acute administration and after extended drug use.
Research Summary of 'Effects of Acute Drug Administration on Emotion: a Review of Pharmacological MRI Studies'
Introduction
Emotional blunting is a recognised feature across several psychiatric conditions, including substance use disorders, and may both precede and follow problematic drug use. Previous work has suggested that psychoactive drugs can alter emotional experience by dampening responses to negative stimuli or by changing the salience of other rewards, but the neural mechanisms remain incompletely described. Pharmacological MRI (phMRI) — the pairing of acute drug administration with task-based functional MRI — provides a translational approach to examine how drugs acutely modulate brain circuits involved in emotion, reward and self-regulation, notably the amygdala, striatum, anterior cingulate and prefrontal cortex. Van Hedger and colleagues set out to review recent phMRI studies that tested the acute effects of commonly used recreational drugs on neural responses during emotion-related tasks in healthy human participants. The authors limited inclusion to studies published in the preceding 15 years that (a) used acute drug administration combined with fMRI, (b) tested healthy humans, and (c) required participants to complete a task involving emotion or mood during scanning. The search used online engines (for example PubMed and Google Scholar) and yielded 21 papers meeting these criteria, which are summarised in the review tables.
Expert Research Summaries
Go Pro to access AI-powered section-by-section summaries, editorial takes, and the full research toolkit.
Study Details
- Study Typemeta
- Journal
- Compound
- Topics
- Authors
- APA Citation
Van Hedger, K., Mayo, L. M., Bershad, A. K., Madray, R., & de Wit, H. (2021). Effects of Acute Drug Administration on Emotion: a Review of Pharmacological MRI Studies. Current Addiction Reports, 8(2), 181-193. https://doi.org/10.1007/s40429-021-00362-y
References (6)
Papers cited by this study that are also in Blossom
Reed, L. J., Nugent, A. C., Furey, M. et al. · Biological Psychiatry (2019)
Schmid, Y., Schmidt, A., Müller, F. et al. · International Journal of Neuropsychopharmacology (2017)
Kraehenmann, R., Preller, K. H., Scheidegger, M. et al. · Biological Psychiatry (2015)
Dolder, P. C., Schmid, Y., Müller, F. et al. · Neuropsychopharmacology (2016)
Mueller, F., Lenz, C., Dolder, P. C. et al. · Translational Psychiatry (2017)
Bershad, A. K., Preller, K. H., Lee, R. et al. · Biological Psychiatry (2020)
Cited By (1)
Papers in Blossom that reference this study
Doss, M. K., de Wit, H., Gallo, D. A. · Psyarxiv (2022)
Your Personal Research Library
Go Pro to save papers, add notes, rate studies, and organize your research into custom shelves.